Gaba Ease
Gaba Ease, licence 80067556: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- GABA Extract
- Licence holder
- Vitanica
- NPN or DIN-HM
- 80067556
- Status
- Active licence
- Licence date
- 9 March 2016
- Revision date
- 27 September 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Humulus lupulus Source : Strobiles Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 300 mg | 75.0 mg | Not calculated |
| Scutellaria lateriflora Source : Sommité Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 300 mg | 75.0 mg | Not calculated |
| Vitamine B6 Source : Vitamine B6 | 12.5 mg | 50,000 µg |
| Acide gamma-aminobutyrique Source : Acide 4-aminobutanoïque | 375.0 mg | Not calculated |
| Passiflora incarnata Source : Sommité Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 375 mg | 75.0 mg | Not calculated |
| L-théanine Source : L-Théanine | 50.0 mg | Not calculated |
Non-medicinal ingredients
Silice, L-Leucine, Cellulose, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Helps to temporarily promote relaxation. Skullcap and hops are traditionally used in Herbal Medicine to help relieve nervousness (sedative and/or calmative).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness.
- Précautions et mises en garde
If symptoms persist or worsen, consult a health care practitioner. Consumption of other medications or natural health products with sedative and/or analgesic properties properties is not recommended. Consult a health care practitioner if sleeplessness persists continuously for more than 3 weeks (chronic insomnia). Consult a health care practitioner prior to use if you have depression and/or related diseases.
- Contre-indications
Do not use if you are pregnant or breastfeeding. Do not use with alcohol.
Source
Official Health Canada record, licence 80067556
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.